paroxetine Tagged Articles
SSRIs, especially Paxil, dangerous to unborn babies
Depression is a serious condition and affects about 10 to 20 percent of pregnant women. One of the most common treatments are selective serotonin reuptake inhibitors, or SSRIs. At one time, the safety of SSRIs treatment during pregnancy and potential
New study shows Paxil during pregnancy causes heart defects
It has been nearly six years since the Food and Drug Administration (FDA) first warned consumers that studies linked the antidepressant Paxil (paroxetine) with an increased risk of birth defects, particularly heart defects, when women take it during the first
Paxil, Seroxat may interfere with man’s ability to conceive
Men who take the antidepressant paroxetine (brand names Paxil or Seroxat) have an increased risk of abnormal sperm DNA that may make it more difficult for them to impregnate a woman, according to Health News Digest.
ACOG Issues Opinion on SSRI Antidepressant Use During Pregnancy
Washington, DC — The use of selective serotonin reuptake inhibitors (SSRIs) and selective norepinephrine reuptake inhibitors for the treatment of depression during pregnancy should be individualized based on their respective risks and benefits, according to a new Committee Opinion issued
Ob/Gyn Group Urges Pregnant Women to Shun Paxil
A group representing America’s obstetricians is recommending that women avoid the antidepressant Paxil if they are pregnant or planning on becoming pregnant, due to a potential heightened risk for birth defects.
Treatment Challenges of Depression in Pregnancy and the Possibility of Persistent Pulmonary Hypertension in Newborns
Decisions about how to treat depression in pregnant women are increasingly complex. Patients and physicians must carefully consider and discuss together the potential benefits and risks of treatment with antidepressants during pregnancy. Two new studies provide important information to be
Updated Product Labeling Warns of Birth Defect
The U.S. Food and Drug Administration (FDA) recently announced that early research studies with the drug Paxil (paroxetine) suggest that taking the drug during the first three months of pregnancy may increase a woman’s risk of having a baby with
FDA Advising of Risk of Birth Defects with Paxil
The Food and Drug Administration today is alerting health care professionals and patients about early results of new studies for Paxil (paroxetine) suggesting that the drug increases the risk for birth defects, particularly heart defects, when women take it during
FDA strengthens pregnancy warning on Glaxo’s Paxil
The Food and Drug Administration said Thursday that the warning label on GlaxoSmithKline’s widely-prescribed anxiety drug Paxil has again been revised to advise the drug may cause heart defects in babies.
New Paxil Labeling Warns Of Birth-Defect Risk
Preliminary study data suggest that the antidepressant paroxetine should not be prescribed to pregnant women.
